Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones

被引:25
作者
Kuntz, Sandra [1 ,2 ]
Mazerbourg, Sabine [1 ,2 ]
Boisbrun, Michel [3 ,4 ]
Cerella, Claudia [5 ]
Diederich, Marc [5 ,6 ]
Grillier-Vuissoz, Isabelle [1 ,2 ]
Flament, Stephane [1 ,2 ]
机构
[1] Univ Lorraine, CRAN, UMR 7039, F-54506 Vandoeuvre Les Nancy, France
[2] CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France
[3] Univ Lorraine, SRSMC, UMR 7565, F-54506 Vandoeuvre Les Nancy, France
[4] CNRS, SRSMC, UMR 7565, F-54506 Vandoeuvre Les Nancy, France
[5] Hop Kirchberg, Lab Biol Mol & Cellulaire Canc, L-2540 Luxembourg, Luxembourg
[6] Seoul Natl Univ, Coll Pharm, Dept Pharm, Seoul 151742, South Korea
基金
新加坡国家研究基金会;
关键词
Cancer; Glucose metabolism; 2-deoxyglucose; Thiazolidinediones; Warburg effect; ACTIVATED-RECEPTOR-GAMMA; TRAIL-INDUCED APOPTOSIS; SENSITIZES TUMOR-CELLS; BREAST-CANCER; PROSTATE-CANCER; DOWN-REGULATION; PPAR-GAMMA; IN-VITRO; TROGLITAZONE DERIVATIVES; LYMPHOBLASTIC-LEUKEMIA;
D O I
10.1016/j.bcp.2014.07.021
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The use of energy restriction mimetic agents (ERMAs) to selectively target cancer cells addicted to glycolysis could be a promising therapeutic approach. Thiazolidinediones (TZDs) are synthetic agonists of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)gamma that were developed to treat type II diabetes. These compounds also display anticancer effects which appear mainly to be independent of their PPAR gamma agonist activity but the molecular mechanisms involved in the anticancer action are not yet well understood. Results obtained on ciglitazone derivatives, mainly in prostate cancer cell models, suggest that these compounds could act as ERMAs. In the present paper, we introduce how compounds like 2-deoxyglucose target the Warburg effect and then we discuss the possibility that the PPAR gamma-independent effects of various TZD could result from their action as ERMAs. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:102 / 111
页数:10
相关论文
共 115 条
[1]
Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death [J].
Aft, RL ;
Zhang, FW ;
Gius, D .
BRITISH JOURNAL OF CANCER, 2002, 87 (07) :805-812
[2]
OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro [J].
Arafa, El-shaimaa A. ;
Abdelazeem, Ahmed H. ;
Arab, Hany H. ;
Omar, Hany A. .
ACTA PHARMACOLOGICA SINICA, 2014, 35 (03) :394-400
[3]
Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation [J].
Aykin-Burns, Nukhet ;
Ahmad, Iman M. ;
Zhu, Yueming ;
Oberley, Larry W. ;
Spitz, Douglas R. .
BIOCHEMICAL JOURNAL, 2009, 418 :29-37
[4]
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells [J].
Ben Sahra, Issam ;
Laurent, Kathiane ;
Giuliano, Sandy ;
Larbret, Frederic ;
Ponzio, Gilles ;
Gounon, Pierre ;
Le Marchand-Brustel, Yannick ;
Giorgetti-Peraldi, Sophie ;
Cormont, Mireille ;
Bertolotto, Corine ;
Deckert, Marcel ;
Auberger, Patrick ;
Tanti, Jean-Francois ;
Bost, Frederic .
CANCER RESEARCH, 2010, 70 (06) :2465-2475
[5]
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response [J].
Ben-Haim, Simona ;
Ell, Peter .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) :88-99
[6]
Suppression of Prostate Epithelial Proliferation and Intraprostatic Progrowth Signaling in Transgenic Mice by a New Energy Restriction-Mimetic Agent [J].
Berman-Booty, Lisa D. ;
Chu, Po-Chen ;
Thomas-Ahner, Jennifer M. ;
Bolon, Brad ;
Wang, Dasheng ;
Yang, Tiffany ;
Clinton, Steven K. ;
Kulp, Samuel K. ;
Chen, Ching-Shih .
CANCER PREVENTION RESEARCH, 2013, 6 (03) :232-241
[7]
Optimization of troglitazone derivatives as potent anti-proliferative agents: Towards more active and less toxic compounds [J].
Bordessa, Andrea ;
Colin-Cassin, Christelle ;
Grillier-Vuissoz, Isabelle ;
Kuntz, Sandra ;
Mazerbourg, Sabine ;
Husson, Gauthier ;
Vo, Myriam ;
Flament, Stephane ;
Martin, Helene ;
Chapleur, Yves ;
Boisbrun, Michel .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 83 :129-140
[8]
Cancer Cell Metabolism [J].
Cairns, R. A. ;
Harris, I. ;
McCracken, S. ;
Mak, T. W. .
METABOLISM AND DISEASE, 2011, 76 :299-311
[9]
CAY O, 1992, CANCER RES, V52, P5794
[10]
Cerquetti L, 2011, EXP CELL RES, V317, P1397